There are 2949 resources available
113P - C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study
Presenter: Florian Posch
Session: E-Poster Display
Resources:
Abstract
114P - PD-L1 prevalence and association with clinical outcomes among metastatic renal cell carcinoma patients treated with targeted therapies
Presenter: Frede Donskov
Session: E-Poster Display
Resources:
Abstract
115P - PD-L1 expression landscape and microsatellite instability status in Chinese endometrial and cervical cancer patients
Presenter: Jin Yang
Session: E-Poster Display
Resources:
Abstract
116P - PD-L1 expression profile and microsatellite instability status in Chinese gastric cancer patients
Presenter: Jianjun Yang
Session: E-Poster Display
Resources:
Abstract
117P - Tumour mutation burden and response to immune checkpoint inhibitors in solid tumors: A systematic review and meta-analysis
Presenter: Khalil Choucair
Session: E-Poster Display
Resources:
Abstract
118P - Correlation between PD-L1 expression/TMB and immune cell infiltration: A pan-cancer study
Presenter: Jianping Xiong
Session: E-Poster Display
Resources:
Abstract
119P - A pan-cancer study on difference of homologous recombination deficiency and tumour mutational burden between Chinese and Western patients
Presenter: Naonao Guo
Session: E-Poster Display
Resources:
Abstract
120P - Predictive biomarkers for hyper progression in response to immune checkpoint inhibitors therapy: Analysis of somatic alterations by NGS
Presenter: Ivan Romarico Gonzalez Espinoza
Session: E-Poster Display
Resources:
Abstract
121P - Relationship between different mutation type in JAK1/2/3 and B2M with other biomarkers for immunotherapy in solid tumours
Presenter: Qing Zhang
Session: E-Poster Display
Resources:
Abstract
122P - Serum PDL-1 in colorectal cancer
Presenter: Lyudmila Akhmaltdinova
Session: E-Poster Display
Resources:
Abstract